Related Experiment Video

Updated: Jan 17, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.1K

The histone lysine methyltransferase NSD3 drives osteosarcomagenesis by inactivating ARID3A

Jinchang Lu1, Yang Shao2, Sanjay Saw2

  • 1Department of Orthopedic Oncology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, PR China; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 1L7, Canada; Department of Musculoskeletal Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, PR China.

Cancer Letters
|September 18, 2025
PubMed

Insights

The study identifies NSD3 as a key driver in osteosarcoma (OS) development, revealing the NSD3-ARID3A pathway. This discovery offers new therapeutic targets for epigenetic drug development in OS patients.

Area of Science:

  • Oncology
  • Epigenetics
  • Genomics

Background:

  • Osteosarcomas (OS) exhibit complex genomic instability, with cancer drivers remaining largely undefined.
  • Understanding the molecular mechanisms driving OS is critical for developing effective treatments.

Purpose of the Study:

  • To identify novel cancer drivers in osteosarcoma using cross-species genomic analysis.
  • To elucidate the role of the NSD3-ARID3A axis in osteosarcomagenesis and its clinical implications.

Main Methods:

  • Cross-species comparative genomics to identify recurrently amplified genes.
  • CRISPR-Cas9 and lentivirus systems for loss- and gain-of-function studies.
  • Analysis of histone modifications (H3K27 di-methylation) and gene expression (RUNX2, MMP13, OCT4, NANOG).

Main Results:

  • Frequent amplification of NSD3, a histone lysine methyltransferase, was identified as a driver in osteosarcoma.
  • The NSD3-ARID3A axis was established as a core pathway, with NSD3 causally promoting OS tumor growth and metastasis.
  • NSD3 enhances H3K27 di-methylation, inactivates ARID3A, and alters expression of key developmental genes, leading to a primitive cell state.

Conclusions:

  • NSD3 overexpression in human OS correlates with poor clinical outcomes.
  • Epigenetic dysregulation of histone lysine methyltransferases, specifically NSD3, is crucial in osteosarcoma.
  • Targeting NSD3 and its pathway presents a promising therapeutic strategy for osteosarcoma using epigenetic drugs.

More Related Videos

Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark10:09

Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark

Published on: January 26, 2018

7.9K
Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells05:27

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

2.2K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.7K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
7.3K
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K